Meeting
2014 Genitourinary Cancers Symposium
PD-L1 expression in non-clear cell renal cell carcinoma.
Authors
André P Fay
Dana-Farber Cancer Institute, Boston, MA
André P Fay , Marcella Callea , Kathryn P. Gray , Thai Huu Ho , Jiaxi Song , Ingrid Carvo , Megan E. Lampron , Melissa L. Stanton , David F. McDermott , Michael B. Atkins , Gordon J Freeman , Michelle S. Hirsch , Sabina Signoretti , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 424)
DOI
10.1200/jco.2014.32.4_suppl.424
Abstract #
424
Poster Bd #
C10
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
PD-L1 expression in non-clear cell renal cell carcinoma and benign kidney tumors.
First Author: Andre Poisl Fay
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Proportion and distribution of PD-L1 expression and associated clinicopathologic features in patients with microsatellite instability-high gastric cancer.
First Author: Sun Mi Lee
Poster
2019 ASCO Annual Meeting
Atezolizumab plus bevacizumab in non-clear cell renal cell carcinoma (NccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (ccRCCsd): Updated results of activity and predictive biomarkers from a phase II study.
First Author: Ronan Flippot
Poster
2019 Genitourinary Cancers Symposium
A phase II study of nivolumab in patients with high-risk biochemically recurrent (BCR) prostate cancer (PCa).
First Author: David Johnson Einstein